Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Neurocrine (DE:NB3)
FRANKFURT:NB3
Neurocrine (NB3) Stock Forecast & Price Target
0 Followers
See the Price Targets and Ratings of:
NB3 Analyst Ratings
Moderate Buy
16 Buy
7 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
NB3 Stock 12 Month Forecast
Average Price Target
€142.58
▲(14.61% Upside)
| Highest Price Target€187.43 | Average Price Target€142.58 | Lowest Price Target€99.34 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Stifel Nicolaus
Reiterated
04/11/24
Mizuho Securities
Reiterated
04/03/24
Canaccord Genuity
Reiterated
03/14/24
Leerink Partners
Reiterated
03/14/24
Robert W. Baird
€147.13
Buy
18.27%
Upside
Reiterated
03/13/24
Analysts Offer Insights on Healthcare Companies: Neurocrine (NASDAQ: NBIX), Arcellx Inc (NASDAQ: ACLX) and Exact Sciences (NASDAQ: EXAS)
UBS
€149.01
Buy
19.78%
Upside
Reiterated
02/20/24
Neurocrine price target raised to $159 from $128 at UBSNeurocrine price target raised to $159 from $128 at UBS
Guggenheim
€153.69
Buy
23.55%
Upside
Reiterated
02/12/24
Neurocrine price target raised to $164 from $157 at GuggenheimNeurocrine price target raised to $164 from $157 at Guggenheim
H.C. Wainwright
€140.57
Buy
13.00%
Upside
Reiterated
02/08/24
Promising Pipeline and Market Positioning Underpin Buy Rating for Neurocrine's Stock (NBIX)
Needham
―
Hold
―
Assigned
02/08/24
Neurocrine's Stable Ingrezza Sales Offset by Higher Expenses: Hold Rating Justified
NB3 Analyst Recommendation Trends
Rating
Dec 23
Jan 24
Feb 24
Mar 24
Apr 24
Strong Buy
0
0
0
0
0
Buy
39
30
37
30
25
Hold
22
19
20
14
13
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
61
49
57
44
38
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
NB3 Financial Forecast
NB3 Stock Forecast FAQ
What is DE:NB3’s average 12-month price target, according to analysts?
Based on analyst ratings, Neurocrine’s 12-month average price target is €142.58.
What is DE:NB3’s upside potential, based on the analysts’ average price target?
Neurocrine has 14.61% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Neurocrine a Buy, Sell or Hold?
Neurocrine has a conensus rating of Moderate Buy, which is based on 16 buy ratings, 7 hold ratings and 0 sell ratings.
What is Neurocrine’s share price target?
The average share price target for Neurocrine is €142.58. This is based on 23 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €187.43 ,and the lowest forecast is €99.34. The average share price target represents 14.61% Increase from the current price of €124.4.
The highest analyst share price target is €187.43 ,and the lowest forecast is €99.34. The average share price target represents 14.61% Increase from the current price of €124.4.
What do analysts say about Neurocrine?
Neurocrine’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 23 Wall Streets Analysts.
How can I buy shares of Neurocrine?
To buy shares of DE:NB3, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.